“…For a birth defect that is characterized by such morbidity surprisingly few robust multicenter data exist including care pathway guidelines. As Koumbourlis et al 2 discuss, most current data emerge from single‐center experience and, here, we agree there is a crucial need for larger‐scale collaborative studies. This manuscript is therefore timely in Pediatric Pulmonology as a “work in progress” consensus on the utility of diagnostic studies and therapeutics addressing respiratory complications of OA–TOF patients.…”